VYSEX Mutual Fund

NAV$16.68

Fund Essentials - as of Feb 28, 2026

Net Assets
$94M
Expense Ratio
0.82%
Dividend Yield (Current)
10.23%
Holdings
168
Inception Date
May 31, 2013
Fund Family
Voya Investment Management
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+18.32%
1 Year+31.21%
3 Year+15.98%
5 Year+7.17%
10 Year+9.59%

Asset Allocation

Stocks: 93.93%
Bonds: 4.32%
Cash: 0.23%
Other: 1.52%

Top Holdings

View All →
TickerNameWeight
MWAMueller Water Products Inc2.87%
CTRECaretrust Reit, Inc.2.28%
FLSFlowserve Corp.2.03%
ALHCAlignment Healthcare1.75%
ARWRArrowhead Pharmaceuticals Inc1.64%
Top 10 Concentration: 17.45%Report Date: Feb 28, 2026
Download all 168 holdings for VYSEX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.23%
Frequency
Annually
Latest Distribution
$3.80
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

VYSEX Mutual Fund Overview

VYSEX Mutual Fund (Voya Small Company Fund Class R6) is managed by Voya Investment Management with $94.5M in net assets. VYSEX expense ratio is 0.82%, holding 168 positions across sectors including Financials, Health Care, Information Technology. Inception date: 2013-05-31.

VYSEX performance shows a YTD return of 18.32%. The 1-year return is 31.21% and the 5-year return is 7.17%. VYSEX dividend yield stands at 10.23%, paid annually.

VYSEX top holdings include Mueller Water Products Inc (2.9%), Caretrust Reit, Inc. (2.3%), Flowserve Corp. (2.0%), Alignment Healthcare (1.8%), Arrowhead Pharmaceuticals Inc (1.6%). View all VYSEX holdings, sector breakdown, or dividend history.

VYSEX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VYSEX alternatives are available via the screener, along with tax-loss harvesting opportunities.